Lamivudine Oral Tablet

Brand(s)
Epivir, Epivir HBV
Category(s)
prescription
SPL Type(s)
Human Prescription
Master SPL
Viiv Healthcare Company (2015-09-30)
Oldest Current Product
1995-11-21
License(s)
NDA, NDA AUTHORIZED GENERIC, ANDA
RxNORM
ORAL TABLET\LAMIVUDINE
FDAOB
ORAL\TABLET\LAMIVUDINE
ORAL\TABLET\LAMIVUDINE: ZIDOVUDINE
SPL Active
ORAL\TABLET, FILM COATED\LAMIVUDINE
ORAL\TABLET\LAMIVUDINE
SPL Moiety
ORAL\TABLET, FILM COATED\LAMIVUDINE
ORAL\TABLET\LAMIVUDINE

product(s) by strength(s)

lamivudine 100 mg oral tablet

original product(s)(s)

#idbrandcategorylabelerfirst marketedactive ingredient(s)routedose formapplicationspl
1001730662Epivir HBVNDAGlaxosmithkline Llc1998-12-17LAMIVUDINEORALTABLET, FILM COATEDNDA0210032df7349c-f5d7-47b5-d29b-1b6b31985591

generic product(s)(s)

#idcategorylabelerfirst marketedactive ingredient(s)routedose formapplicationspl
1003785168ANDAMylan Pharmaceuticals Inc.2015-01-09LAMIVUDINEORALTABLET, FILM COATEDANDA204002e54278ea-25d9-46a5-9dd0-9d5c6ac4cc4f
2317220752ANDACamber Pharmaceuticals, Inc.2014-01-02LAMIVUDINEORALTABLET, FILM COATEDANDA2032606bd6b9da-df69-46db-813e-4e7f3bdecf95
3605053250ANDAApotex Corp2014-01-03LAMIVUDINEORALTABLET, FILM COATEDANDA20294187095352-c088-74b1-7be0-d3e293a90611
4669930478NDA AUTHORIZED GENERICPrasco Laboratories2014-09-05LAMIVUDINEORALTABLET, FILM COATEDNDA021003a5b963ec-b139-4e28-b447-b72c9e710c1f

relabeler product(s)(s)

#idbrandcategorylabelerfirst marketedactive ingredient(s)routedose formequivalent productapplicationspl
1001790152ANDAKaiser Foundations Hospitals2014-05-29LAMIVUDINEORALTABLET, FILM COATED605053250ANDA2029414fba8971-1f57-457d-808a-fadbb2580830
2001790172ANDAKaiser Foundations Hospitals2015-03-20LAMIVUDINEORALTABLET, FILM COATED317220752ANDA203260cc11a8df-7b7d-40f6-bd0b-b01ddadae917
3538080893Epivir HBVNDAState Of Florida Doh Central Pharmacy2014-01-01LAMIVUDINEORALTABLET, FILM COATED001730662NDA02100383009c27-f54b-47df-b8b2-e2e4e0b8f4e8

lamivudine 150 mg oral tablet

original product(s)(s)

#idbrandcategorylabelerfirst marketedactive ingredient(s)routedose formapplicationspl
1497020203EpivirNDAViiv Healthcare Company2010-10-04LAMIVUDINEORALTABLET, FILM COATEDNDA02056489226149-47fa-4f7d-bb1f-1aa7034486b8

generic product(s)(s)

#idcategorylabelerfirst marketedactive ingredient(s)routedose formapplicationspl
1317220753ANDACamber Pharmaceuticals, Inc.2014-01-06LAMIVUDINEORALTABLET, FILM COATEDANDA20327749d53e74-3798-4463-b817-1c8beb755034
2605053251ANDAApotex Corp2011-12-02LAMIVUDINEORALTABLET, FILM COATEDANDA09160634c02bcc-d6ff-99d4-8e6a-4a91908adca8
3658620552ANDAAurobindo Pharma Limited2011-11-17LAMIVUDINEORALTABLET, FILM COATEDANDA202032bd55dd57-348c-4d78-b322-d1ae10279298
4681800602ANDALupin Pharmaceuticals, Inc.2015-03-25LAMIVUDINEORALTABLET, FILM COATEDANDA205217ff3b5265-f533-4332-a861-d8c9c1664ffd

relabeler product(s)(s)

#idbrandcategorylabelerfirst marketedactive ingredient(s)routedose formequivalent productapplicationspl
1001790087EpivirNDAKaiser Foundations Hospitals2011-03-15LAMIVUDINEORALTABLET, FILM COATED497020203NDA0205641c3ba0b0-0352-49e8-b5cd-9df698194988
2216950367EpivirNDARebel Distributors Corp1995-11-21LAMIVUDINEORALTABLET, FILM COATED001730470NDA020564166abd26-675e-4832-9d18-0567f2a9d4e4
3242360271EpivirNDARemedyrepack Inc.2013-03-15LAMIVUDINEORALTABLET, FILM COATED001730470NDA020564ffeab230-2e5c-4d85-bc88-5980b7e7d81b
4493490676EpivirNDARemedyrepack Inc.2011-07-13, 2011-09-13LAMIVUDINEORALTABLET, FILM COATED497020203NDA0205643b1f8ee3-d582-4faa-a7f2-0fbc45721298, 97a9dfe0-4c36-4733-aa06-c2cd2a1f1ca6
5493490885ANDARemedyrepack Inc.2013-04-11LAMIVUDINEORALTABLET, FILM COATED658620552ANDA2020320d564c2a-de2c-4c2d-ad5b-d910174debc2, 104defcb-720d-4a27-806f-2c0c117b2bac, ada39596-ddcb-46a1-b6fc-962fb1512a80
6493490896ANDARemedyrepack Inc.2013-04-11LAMIVUDINEORALTABLET, FILM COATED000935385ANDA0790813ce0b713-c4a7-4dc0-a6f8-89a7b11716b7, 6c4fa641-e39c-4327-a127-d24a6103ef52
7502680459ANDAAvpak2015-07-30LAMIVUDINEORALTABLET, FILM COATED317220753ANDA203277120a47ff-e3a5-8811-3428-e90704ca0679
8538080245EpivirNDAState Of Florida Doh Central Pharmacy2009-07-01LAMIVUDINEORALTABLET, FILM COATED001730470NDA02056413ca868d-a734-4c2f-88f0-ac1071ba7311
9538080843ANDAState Of Florida Doh Central Pharmacy2013-01-01LAMIVUDINEORALTABLET, FILM COATED605053251ANDA09160626182670-f400-49b8-92e7-f0124920af78
10548683693EpivirNDAPhysicians Total Care, Inc.1995-12-01LAMIVUDINEORALTABLET, FILM COATED00173047001NDA02056489b6f044-fe14-4e38-b5ea-a3c525d29dd6
11604290353ANDAGolden State Medical Supply, Inc.2011-12-02LAMIVUDINEORALTABLET, FILM COATED605053251ANDA091606f3637209-303e-4232-ae79-07315a990973
12617860320ANDARemedyrepack Inc.2015-05-30, 2015-06-19, 2015-07-03LAMIVUDINEORALTABLET, FILM COATED317220753ANDA20327727752574-f6bf-4557-8e4e-a077b6f0b116, 7eaa1b82-d25a-4b8f-bf31-d837faf5aff9, dc20a4d1-5459-489c-8b3a-3c260ede105d
13636295014ANDABryant Ranch Prepack2011-11-17LAMIVUDINEORALTABLET, FILM COATED658620552ANDA20203209131b4d-efcd-435f-8b7c-8738f78e5bf9
14680840578ANDAAmerican Health Packaging2012-02-01LAMIVUDINEORALTABLET, FILM COATED658620552ANDA202032b77dd52f-3506-445c-989b-916f844633f6

lamivudine 300 mg oral tablet

original product(s)(s)

#idbrandcategorylabelerfirst marketedactive ingredient(s)routedose formapplicationspl
1497020204EpivirNDAViiv Healthcare Company2010-10-04LAMIVUDINEORALTABLET, FILM COATEDNDA02056489226149-47fa-4f7d-bb1f-1aa7034486b8

generic product(s)(s)

#idcategorylabelerfirst marketedactive ingredient(s)routedose formapplicationspl
1317220754ANDACamber Pharmaceuticals, Inc.2014-01-06LAMIVUDINEORALTABLET, FILM COATEDANDA20327749d53e74-3798-4463-b817-1c8beb755034
2605053252ANDAApotex Corp2011-12-02LAMIVUDINEORALTABLET, FILM COATEDANDA09160634c02bcc-d6ff-99d4-8e6a-4a91908adca8
3658620553ANDAAurobindo Pharma Limited2011-11-17LAMIVUDINEORALTABLET, FILM COATEDANDA202032bd55dd57-348c-4d78-b322-d1ae10279298

relabeler product(s)(s)

#idbrandcategorylabelerfirst marketedactive ingredient(s)routedose formequivalent productapplicationspl
1493490713EpivirNDARemedyrepack Inc.2011-08-30LAMIVUDINEORALTABLET497020204NDA020564bc62b38c-4cc9-4e64-8852-1a0be6d36d8e
2502680460ANDAAvpak2015-07-30LAMIVUDINEORALTABLET, FILM COATED317220754ANDA203277120a47ff-e3a5-8811-3428-e90704ca0679
3521250016ANDARemedyrepack Inc.2013-03-28LAMIVUDINEORALTABLET, FILM COATED658620553ANDA2020322f1b5d5a-c2f8-48af-8bdc-67e7dd664436
4538080246EpivirNDAState Of Florida Doh Central Pharmacy2009-07-01LAMIVUDINEORALTABLET, FILM COATED001730714NDA02056413ca868d-a734-4c2f-88f0-ac1071ba7311
5538080844ANDAState Of Florida Doh Central Pharmacy2013-01-01LAMIVUDINEORALTABLET, FILM COATED605053252ANDA09160626182670-f400-49b8-92e7-f0124920af78
6548685416EpivirNDAPhysicians Total Care, Inc.2007-09-28LAMIVUDINEORALTABLET, FILM COATED00173071400NDA02056489b6f044-fe14-4e38-b5ea-a3c525d29dd6
7604290354ANDAGolden State Medical Supply, Inc.2011-12-02LAMIVUDINEORALTABLET, FILM COATED605053252ANDA091606f3637209-303e-4232-ae79-07315a990973

application(s)

#idtitleapplicantapprovedpatentexclusivityapproved drugin other drug docs
1ANDA079081LAMIVUDINE AND ZIDOVUDINETEVA PHARMACEUTICALS USA2011-05-25ANDA079081_001Lamivudine / Zidovudine Oral Tablet
2ANDA079124LAMIVUDINE AND ZIDOVUDINEHETERO LABS LTD UNIT III2015-09-17ANDA079124_001Lamivudine / Zidovudine Oral Tablet
3ANDA079128LAMIVUDINE AND ZIDOVUDINESTRIDES PHARMA GLOBAL PTE LTD2015-05-13ANDA079128_001Lamivudine / Zidovudine Oral Tablet
4ANDA090246LAMIVUDINE AND ZIDOVUDINELUPIN LTD2012-05-15ANDA090246_001Lamivudine / Zidovudine Oral Tablet
5ANDA091606LAMIVUDINEAPOTEX INC2011-12-02ANDA091606_001, ANDA091606_002
6ANDA202032LAMIVUDINEAUROBINDO PHARMA LTD2011-11-17ANDA202032_001, ANDA202032_002
7ANDA202418LAMIVUDINE AND ZIDOVUDINEAUROBINDO PHARMA LTD2012-05-15ANDA202418_001Lamivudine / Zidovudine Oral Tablet
8ANDA202941LAMIVUDINEAPOTEX INC2014-01-02ANDA202941_001
9ANDA203259LAMIVUDINE AND ZIDOVUDINEHETERO LABS LTD UNIT V2014-02-03ANDA203259_001Lamivudine / Zidovudine Oral Tablet
10ANDA203260LAMIVUDINEHETERO LABS LTD UNIT V2014-01-02ANDA203260_001
11ANDA203277LAMIVUDINEHETERO LABS LTD UNIT V2014-01-06ANDA203277_001, ANDA203277_002
12ANDA204002LAMIVUDINEMYLAN PHARMACEUTICALS INC2014-12-31ANDA204002_001
13ANDA204005LAMIVUDINE AND ZIDOVUDINEMYLAN PHARMACEUTICALS INC2014-08-28ANDA204005_001Lamivudine / Zidovudine Oral Tablet
14ANDA205217LAMIVUDINELUPIN LTD2014-12-18ANDA205217_001, ANDA205217_002
15NDA020564EPIVIRVIIV HEALTHCARE CO1995-11-17p5905082, SUBSTANCEONCE DAILY DOSING IN PEDIATRIC PATIENTS 3 MONTHS OF AGE AND OLDER IN COMBINATION WITH OTHER ANTIRETROVIRAL AGENTS FOR THE TREATMENT OF HIV-1 INFECTION [2018-03-23]NDA020564_001, NDA020564_003
16NDA020857COMBIVIRVIIV HEALTHCARE CO1997-09-26p5905082, TREATMENT OF HIV, SUBSTANCENDA020857_001Lamivudine / Zidovudine Oral Tablet
17NDA021003EPIVIR-HBVGLAXOSMITHKLINE1998-12-08p5905082NDA021003_001

application drug(s)

#idcategory/deprecatedingredient strength(s)routedose formrldTEapprovedapplication
1ANDA079081_001RXLAMIVUDINE (150MG), ZIDOVUDINE (300MG)ORALTABLETFalseAB2011-05-25LAMIVUDINE AND ZIDOVUDINE
2ANDA079124_001RXZIDOVUDINE (300MG), LAMIVUDINE (150MG)ORALTABLETFalseAB2015-09-17LAMIVUDINE AND ZIDOVUDINE
3ANDA079128_001RXLAMIVUDINE (150MG), ZIDOVUDINE (300MG)ORALTABLETFalseAB2015-05-13LAMIVUDINE AND ZIDOVUDINE
4ANDA090246_001RXZIDOVUDINE (300MG), LAMIVUDINE (150MG)ORALTABLETFalseAB2012-05-15LAMIVUDINE AND ZIDOVUDINE
5ANDA091606_001RXLAMIVUDINE (150MG)ORALTABLETFalseAB2011-12-02LAMIVUDINE
6ANDA091606_002RXLAMIVUDINE (300MG)ORALTABLETFalseAB2011-12-02LAMIVUDINE
7ANDA202032_001RXLAMIVUDINE (150MG)ORALTABLETFalseAB2011-11-17LAMIVUDINE
8ANDA202032_002RXLAMIVUDINE (300MG)ORALTABLETFalseAB2011-11-17LAMIVUDINE
9ANDA202418_001RXZIDOVUDINE (300MG), LAMIVUDINE (150MG)ORALTABLETFalseAB2012-05-15LAMIVUDINE AND ZIDOVUDINE
10ANDA202941_001RXLAMIVUDINE (100MG)ORALTABLETFalseAB2014-01-02LAMIVUDINE
11ANDA203259_001RXZIDOVUDINE (300MG), LAMIVUDINE (150MG)ORALTABLETFalseAB2014-02-03LAMIVUDINE AND ZIDOVUDINE
12ANDA203260_001RXLAMIVUDINE (100MG)ORALTABLETFalseAB2014-01-02LAMIVUDINE
13ANDA203277_001RXLAMIVUDINE (150MG)ORALTABLETFalseAB2014-01-06LAMIVUDINE
14ANDA203277_002RXLAMIVUDINE (300MG)ORALTABLETFalseAB2014-01-06LAMIVUDINE
15ANDA204002_001RXLAMIVUDINE (100MG)ORALTABLETFalseAB2014-12-31LAMIVUDINE
16ANDA204005_001RXLAMIVUDINE (150MG), ZIDOVUDINE (300MG)ORALTABLETFalseAB2014-08-28LAMIVUDINE AND ZIDOVUDINE
17ANDA205217_001RXLAMIVUDINE (150MG)ORALTABLETFalseAB2014-12-18LAMIVUDINE
18ANDA205217_002RXLAMIVUDINE (300MG)ORALTABLETFalseAB2014-12-18LAMIVUDINE
19NDA020564_001RXLAMIVUDINE (150MG)ORALTABLETFalseAB1995-11-17EPIVIR
20NDA020564_003RXLAMIVUDINE (300MG)ORALTABLETTrueAB2002-06-24EPIVIR
21NDA020857_001RXZIDOVUDINE (300MG), LAMIVUDINE (150MG)ORALTABLETTrueAB1997-09-26COMBIVIR
22NDA021003_001RXLAMIVUDINE (100MG)ORALTABLETTrueAB1998-12-08EPIVIR-HBV

patent(s)

#idexpiration dateapplication(s)in other drug docs
1p5905082 (view patent)2016-05-18NDA020564, NDA020857, NDA021003, NDA020596, NDA021205, NDA021652, NDA205551abacavir / Lamivudine Oral Tablet
abacavir / dolutegravir / Lamivudine Oral Tablet
abacavir / Lamivudine / Zidovudine Oral Tablet
Lamivudine / Zidovudine Oral Tablet
Lamivudine Oral Solution

spl(s)

#idtitlecategorytypelabelerlabeler actlast updateversionproduct(s)in other drug docs
109131b4d-efcd-435f-8b7c-8738f78e5bf9 (view SPL)These highlights do not include all the information needed to use lamivudine safely and effectively. See full prescribing information for lamivudine tablets. Lamivudine TabletsInitial U.S. Approval: 1995prescriptionHuman PrescriptionBryant Ranch PrepackRELABEL, REPACK2013-11-121000636295014
20d564c2a-de2c-4c2d-ad5b-d910174debc2 (view SPL)These highlights do not include all the information needed to use lamivudine safely and effectively. See full prescribing information for lamivudine tablets.Lamivudine TabletsInitial U.S. Approval: 1995prescriptionHuman PrescriptionRemedyrepack Inc.2013-04-111493490885
3104defcb-720d-4a27-806f-2c0c117b2bac (view SPL)These highlights do not include all the information needed to use lamivudine safely and effectively. See full prescribing information for lamivudine tablets.Lamivudine TabletsInitial U.S. Approval: 1995prescriptionHuman PrescriptionRemedyrepack Inc.2013-04-111493490885
4120a47ff-e3a5-8811-3428-e90704ca0679 (view SPL)These highlights do not include all the information needed to use lamivudine safely and effectively. See full prescribing information for lamivudine.Initial U.S. Approval: 1995prescriptionHuman PrescriptionAvpak2015-07-301502680459, 502680460
513ca868d-a734-4c2f-88f0-ac1071ba7311 (view SPL)These highlights do not include all the information needed to use EPIVIR safely and effectively. See full prescribing information for EPIVIR.EPIVIR (lamivudine) Tablets and Oral SolutionInitial U.S. Approval: 1995prescriptionHuman PrescriptionState Of Florida Doh Central Pharmacyrepack2010-04-131538080245, 538080246
6166abd26-675e-4832-9d18-0567f2a9d4e4 (view SPL)These highlights do not include all the information needed to use EPIVIR safely and effectively. See full prescribing information for EPIVIR.EPIVIR (lamivudine) Tablets and Oral SolutionInitial U.S. Approval: 1995prescriptionHuman PrescriptionRebel Distributors CorpRELABEL, REPACK2010-09-241216950367
71c3ba0b0-0352-49e8-b5cd-9df698194988 (view SPL)These highlights do not include all the information needed to use EPIVIR safely and effectively. See full prescribing information for EPIVIR.EPIVIR (lamivudine) Tablets and Oral SolutionInitial U.S. Approval: 1995prescriptionHuman PrescriptionKaiser Foundations Hospitalsrepack2011-03-312001790087
826182670-f400-49b8-92e7-f0124920af78 (view SPL)These highlights do not include all the information needed to use lamivudine tablets safely and effectively. See full prescribing information for lamivudine tablets. Lamivudine Tablets 150 mg and 300 mg, for oral use Initial U.S. Approval: 1995prescriptionHuman PrescriptionState Of Florida Doh Central Pharmacyrepack2013-09-121538080843, 538080844
927752574-f6bf-4557-8e4e-a077b6f0b116 (view SPL)These highlights do not include all the information needed to use lamivudine safely and effectively. See full prescribing information for lamivudine.Lamivudine TabletsInitial U.S. Approval: 1995Rx OnlyprescriptionHuman PrescriptionRemedyrepack Inc.2015-05-301617860320
102df7349c-f5d7-47b5-d29b-1b6b31985591 (view SPL)These highlights do not include all the information needed to use EPIVIR-HBV safely and effectively. See full prescribing information for EPIVIR-HBV.EPIVIR-HBV (lamivudine) tablets for oral useEPIVIR-HBV (lamivudine) oral solutionInitial U.S. Approval: 1995prescriptionHuman PrescriptionGlaxosmithkline Llc2013-12-2014001730662, 001730663Lamivudine Oral Solution
112f1b5d5a-c2f8-48af-8bdc-67e7dd664436 (view SPL)These highlights do not include all the information needed to use lamivudine safely and effectively. See full prescribing information for lamivudine tablets.Lamivudine TabletsInitial U.S. Approval: 1995prescriptionHuman PrescriptionRemedyrepack Inc.2013-03-282521250016
1234c02bcc-d6ff-99d4-8e6a-4a91908adca8 (view SPL)These highlights do not include all the information needed to use LAMIVUDINE TABLETS safely and effectively. See full prescribing information for LAMIVUDINE TABLETS. LAMIVUDINE tablets, for oral use Initial U.S. Approval: 1995prescriptionHuman PrescriptionApotex Corpanalysis, manufacture2015-10-2015605053251, 605053252
133b1f8ee3-d582-4faa-a7f2-0fbc45721298 (view SPL)prescriptionHuman PrescriptionRemedyrepack Inc.2011-07-131493490676
143ce0b713-c4a7-4dc0-a6f8-89a7b11716b7 (view SPL)These highlights do not include all the information needed to use lamivudine and zidovudine tablets USP safely and effectively. See full prescribing information for lamivudine and zidovudine tablets USP.LAMIVUDINE and ZIDOVUDINE tablets, USP 150 mg/300 mg for oral use Initial U.S. Approval: 1997prescriptionHuman PrescriptionRemedyrepack Inc.2013-04-112493490896
1549d53e74-3798-4463-b817-1c8beb755034 (view SPL)These highlights do not include all the information needed to useLAMIVUDINE TABLETSsafely and effectively. See full prescribing information for LAMIVUDINE TABLETS.LAMIVUDINE TabletsInitial U.S. Approval: 1995prescriptionHuman PrescriptionCamber Pharmaceuticals, Inc.ANALYSIS, MANUFACTURE2015-10-143317220753, 317220754
164fba8971-1f57-457d-808a-fadbb2580830 (view SPL)These highlights do not include all the information needed to use LAMIVUDINE Tablets (HBV) safely and effectively. See full prescribing information for LAMIVUDINE Tablets (HBV). LAMIVUDINE Tablets (HBV) for oral us INITIAL U.S. APPROVAL: 1995prescriptionHuman PrescriptionKaiser Foundations Hospitalsrepack2014-05-301001790152
176bd6b9da-df69-46db-813e-4e7f3bdecf95 (view SPL)These highlights do not include all the information needed to use lamivudine tablets (HBV) safely and effectively. See full prescribing information for lamivudine tablets (HBV).LAMIVUDINE Tablets (HBV) for oral use Initial U.S. Approval: 1995prescriptionHuman PrescriptionCamber Pharmaceuticals, Inc.ANALYSIS, MANUFACTURE2013-12-311317220752
186c4fa641-e39c-4327-a127-d24a6103ef52 (view SPL)These highlights do not include all the information needed to use lamivudine and zidovudine tablets USP safely and effectively. See full prescribing information for lamivudine and zidovudine tablets USP.LAMIVUDINE and ZIDOVUDINE tablets, USP 150 mg/300 mg for oral use Initial U.S. Approval: 1997prescriptionHuman PrescriptionRemedyrepack Inc.2013-04-111493490896
197eaa1b82-d25a-4b8f-bf31-d837faf5aff9 (view SPL)These highlights do not include all the information needed to use lamivudine safely and effectively. See full prescribing information for lamivudine.Lamivudine TabletsInitial U.S. Approval: 1995Rx OnlyprescriptionHuman PrescriptionRemedyrepack Inc.2015-07-031617860320
2083009c27-f54b-47df-b8b2-e2e4e0b8f4e8 (view SPL)These highlights do not include all the information needed to use EPIVIR-HBV safely and effectively. See full prescribing information for EPIVIR-HBV.EPIVIR-HBV (lamivudine) tablets for oral useEPIVIR-HBV (lamivudine) oral solutionInitial U.S. Approval: 1995prescriptionHuman PrescriptionState Of Florida Doh Central Pharmacyrepack2014-03-031538080893
2187095352-c088-74b1-7be0-d3e293a90611 (view SPL)These highlights do not include all the information needed to use LAMIVUDINE Tablets (HBV) safely and effectively. See full prescribing information for LAMIVUDINE Tablets (HBV). LAMIVUDINE Tablets (HBV) for oral us INITIAL U.S. APPROVAL: 1995prescriptionHuman PrescriptionApotex Corpanalysis, manufacture2013-12-262605053250
2289226149-47fa-4f7d-bb1f-1aa7034486b8 (view SPL)These highlights do not include all the information needed to use EPIVIR safely and effectively. See full prescribing information for EPIVIR.EPIVIR (lamivudine) tablets for oral useEPIVIR (lamivudine) oral solutionInitial U.S. Approval: 1995prescriptionHuman PrescriptionViiv Healthcare Company2015-09-3011497020203, 497020204, 497020205Lamivudine Oral Solution
2389b6f044-fe14-4e38-b5ea-a3c525d29dd6 (view SPL)These highlights do not include all the information needed to use EPIVIR safely and effectively. See full prescribing information for EPIVIR.EPIVIR (lamivudine) Tablets and Oral SolutionInitial U.S. Approval: 1995prescriptionHuman PrescriptionPhysicians Total Care, Inc.relabel, repack2010-04-141548683693, 548685416
2497a9dfe0-4c36-4733-aa06-c2cd2a1f1ca6 (view SPL)prescriptionHuman PrescriptionRemedyrepack Inc.2011-09-131493490676
25a5b963ec-b139-4e28-b447-b72c9e710c1f (view SPL)These highlights do not include all the information needed to use Lamivudine tablets (HBV) safely and effectively. See full prescribing information for Lamivudine tablets (HBV).Lamivudine tablets (HBV) for oral useInitial U.S. Approval: 1995prescriptionHuman PrescriptionPrasco Laboratories2014-04-302669930478
26ada39596-ddcb-46a1-b6fc-962fb1512a80 (view SPL)These highlights do not include all the information needed to use lamivudine safely and effectively. See full prescribing information for lamivudine tablets.Lamivudine TabletsInitial U.S. Approval: 1995prescriptionHuman PrescriptionRemedyrepack Inc.2013-04-111493490885
27b77dd52f-3506-445c-989b-916f844633f6 (view SPL)These highlights do not include all the information needed to use lamivudine safely and effectively. See full prescribing information for lamivudine tablets. Lamivudine Tablets Initial U.S. Approval: 1995prescriptionHuman PrescriptionAmerican Health Packagingrepack2015-10-202680840578
28bc62b38c-4cc9-4e64-8852-1a0be6d36d8e (view SPL)prescriptionHuman PrescriptionRemedyrepack Inc.2011-08-301493490713
29bd55dd57-348c-4d78-b322-d1ae10279298 (view SPL)These highlights do not include all the information needed to use LAMIVUDINE TABLETS safely and effectively. See full prescribing information for LAMIVUDINE TABLETS. LAMIVUDINE tablets for oral useInitial U.S. Approval: 1995prescriptionHuman PrescriptionAurobindo Pharma LimitedANALYSIS, API MANUFACTURE, MANUFACTURE2015-07-313658620552, 658620553
30cc11a8df-7b7d-40f6-bd0b-b01ddadae917 (view SPL)These highlights do not include all the information needed to use lamivudine tablets (HBV) safely and effectively. See full prescribing information for lamivudine tablets (HBV).LAMIVUDINE Tablets (HBV) for oral use Initial U.S. Approval: 1995prescriptionHuman PrescriptionKaiser Foundations Hospitalsrepack2015-04-221001790172
31dc20a4d1-5459-489c-8b3a-3c260ede105d (view SPL)These highlights do not include all the information needed to use lamivudine safely and effectively. See full prescribing information for lamivudine.Lamivudine TabletsInitial U.S. Approval: 1995Rx OnlyprescriptionHuman PrescriptionRemedyrepack Inc.2015-06-191617860320
32e54278ea-25d9-46a5-9dd0-9d5c6ac4cc4f (view SPL)These highlights do not include all the information needed to use lamivudine tablets safely and effectively. See full prescribing information for lamivudine tablets.LAMIVUDINE tablets for oral useInitial U.S. Approval: 1995prescriptionHuman PrescriptionMylan Pharmaceuticals Inc.2014-02-191003785168
33f3637209-303e-4232-ae79-07315a990973 (view SPL)These highlights do not include all the information needed to use Lamivudine, USP safely and effectively. See full prescribing information for Lamivudine, USP.Initial U.S. Approval: 1995prescriptionHuman PrescriptionGolden State Medical Supply, Inc.RELABEL, REPACK2012-01-091604290353, 604290354
34ff3b5265-f533-4332-a861-d8c9c1664ffd (view SPL)These highlights do not include all the information needed to use LAMIVUDINE TABLETS safely and effectively. See full prescribing information for LAMIVUDINE TABLETS. LAMIVUDINE tablets, for oral use Initial U.S. Approval: 1995prescriptionHuman PrescriptionLupin Pharmaceuticals, Inc.manufacture2015-12-017681800602
35ffeab230-2e5c-4d85-bc88-5980b7e7d81b (view SPL)These highlights do not include all the information needed to use EPIVIR safely and effectively. See full prescribing information for EPIVIR.EPIVIR (lamivudine) Tablets and Oral SolutionInitial U.S. Approval: 1995prescriptionHuman PrescriptionRemedyrepack Inc.2013-03-151242360271

Data from: FDAOB, FDAPB, LOINC, MTHSPL, NDFRT, NCIT, RxNORM, UNII